JP2023521116A5 - - Google Patents
Info
- Publication number
- JP2023521116A5 JP2023521116A5 JP2022561396A JP2022561396A JP2023521116A5 JP 2023521116 A5 JP2023521116 A5 JP 2023521116A5 JP 2022561396 A JP2022561396 A JP 2022561396A JP 2022561396 A JP2022561396 A JP 2022561396A JP 2023521116 A5 JP2023521116 A5 JP 2023521116A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- alkyl
- compound
- salt
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063008183P | 2020-04-10 | 2020-04-10 | |
| US63/008,183 | 2020-04-10 | ||
| US202063027495P | 2020-05-20 | 2020-05-20 | |
| US63/027,495 | 2020-05-20 | ||
| PCT/US2021/022656 WO2021206876A1 (en) | 2020-04-10 | 2021-03-17 | Inhibitors of norovirus and coronavirus replication |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521116A JP2023521116A (ja) | 2023-05-23 |
| JP2023521116A5 true JP2023521116A5 (https=) | 2024-03-26 |
| JP7721561B2 JP7721561B2 (ja) | 2025-08-12 |
Family
ID=75439538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561396A Active JP7721561B2 (ja) | 2020-04-10 | 2021-03-17 | ノロウイルス及びコロナウイルス複製の阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230159453A1 (https=) |
| EP (1) | EP4132944A1 (https=) |
| JP (1) | JP7721561B2 (https=) |
| KR (1) | KR20230008079A (https=) |
| CN (1) | CN115698035A (https=) |
| AU (1) | AU2021254045A1 (https=) |
| BR (1) | BR112022019557A2 (https=) |
| CA (1) | CA3179697A1 (https=) |
| IL (1) | IL297069A (https=) |
| MX (1) | MX2022012714A (https=) |
| PH (1) | PH12022552486A1 (https=) |
| TW (1) | TW202204318A (https=) |
| WO (1) | WO2021206876A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4126816A4 (en) * | 2020-03-30 | 2024-07-31 | Kansas State University Research Foundation | BROAD-SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US20220033383A1 (en) | 2020-07-20 | 2022-02-03 | Enanta Pharmaceuticals, Inc. | Functionalized peptides as antiviral agents |
| US11351149B2 (en) * | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| KR20230124583A (ko) | 2020-11-23 | 2023-08-25 | 이난타 파마슈티칼스, 인코포레이티드 | 신규한 스피로피롤리딘 유래 항바이러스제 |
| US11384090B2 (en) | 2020-11-23 | 2022-07-12 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12540141B2 (en) | 2020-11-23 | 2026-02-03 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11352363B1 (en) | 2020-11-23 | 2022-06-07 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2022156693A1 (zh) * | 2021-01-19 | 2022-07-28 | 中国人民解放军军事科学院军事医学研究院 | 含有n-(取代磺酰基)乙酰胺结构的病毒蛋白酶抑制剂，及其在抗病毒药物中的应用 |
| US20240307419A1 (en) * | 2021-01-29 | 2024-09-19 | Kansas State University Research Foundation | Conformationally-constrained inhibitors of 3c or 3c-like proteases |
| WO2022235605A1 (en) | 2021-05-04 | 2022-11-10 | Enanta Pharmaceuticals, Inc. | Novel macrocyclic antiviral agents |
| US11319325B1 (en) | 2021-05-11 | 2022-05-03 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| US12398147B2 (en) | 2021-05-11 | 2025-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| WO2022256434A1 (en) * | 2021-06-02 | 2022-12-08 | ACEA Therapeutics, Inc. | Protease inhibitors as antivirals |
| US20230033285A1 (en) * | 2021-06-16 | 2023-02-02 | The Scripps Research Institute | Protease Inhibitors for Treatment of Coronavirus Infections |
| US11325916B1 (en) | 2021-07-29 | 2022-05-10 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11339170B1 (en) | 2021-07-23 | 2022-05-24 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12479854B2 (en) | 2021-07-29 | 2025-11-25 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| IL310394A (en) * | 2021-08-03 | 2024-03-01 | Cocrystal Pharma Inc | Corona virus inhibitors |
| US11858945B2 (en) | 2021-11-12 | 2024-01-02 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| US11919910B2 (en) | 2021-11-12 | 2024-03-05 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11912714B2 (en) | 2021-11-12 | 2024-02-27 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12145941B2 (en) | 2021-12-08 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Heterocyclic antiviral agents |
| WO2023107419A1 (en) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| US20250223259A1 (en) * | 2022-01-07 | 2025-07-10 | Merck Sharp & Dohme Llc | Protease inhibitors for treating or preventing coronavirus infection |
| JP2025507472A (ja) * | 2022-03-01 | 2025-03-21 | ウエストバック バイオファーマ カンパニー リミテッド | ケトアミド系誘導体及びその製薬における使用 |
| WO2023196307A1 (en) | 2022-04-05 | 2023-10-12 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| CN115260074B (zh) * | 2022-08-02 | 2024-06-21 | 爱斯特（成都）生物制药股份有限公司 | 一种口服抗病毒药物Paxlovid中间体的制备方法 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093709A (en) | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
| US4131648A (en) | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
| US4180646A (en) | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
| US4079038A (en) | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
| GB2064336B (en) | 1979-12-06 | 1984-03-14 | Glaxo Group Ltd | Device for dispensing medicaments |
| US4304767A (en) | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
| US4353656A (en) | 1980-10-14 | 1982-10-12 | Xerox Corporation | Moving coil, multiple energy print hammer system including a closed loop servo |
| DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
| GB2129691B (en) | 1982-10-08 | 1987-08-05 | Glaxo Group Ltd | Devices for administering medicaments to patients |
| US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
| GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
| US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| US4753788A (en) | 1985-01-31 | 1988-06-28 | Vestar Research Inc. | Method for preparing small vesicles using microemulsification |
| AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| US4946931A (en) | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
| CA2070823C (en) | 1989-12-05 | 1999-01-12 | William H. Ii Frey | Neurologic agents for nasal administration to the brain |
| GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US5968543A (en) | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| AU6526100A (en) | 1999-08-06 | 2001-03-05 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
| US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
| US7252840B1 (en) | 1999-08-25 | 2007-08-07 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles |
| US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
| US6632666B2 (en) | 2000-01-14 | 2003-10-14 | Biolife Solutions, Inc. | Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media |
| US6613355B2 (en) | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| WO2002013897A2 (en) | 2000-08-14 | 2002-02-21 | Advanced Inhalation Research, Inc. | Inhalation device and method |
| JP2005504715A (ja) | 2000-12-29 | 2005-02-17 | アドバンスト インハレーション リサーチ，インコーポレイテッド | 持続放出特性を有する吸入用粒子 |
| US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US6848197B2 (en) | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
| US6524606B1 (en) | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
| AU2002352836B2 (en) | 2001-11-20 | 2005-09-29 | Alkermes, Inc. | Improved particulate compositions for pulmonary delivery |
| US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
| EP1673123A2 (en) | 2003-09-05 | 2006-06-28 | Kurve Technology, Inc. | Integrated nebulizer and particle dispersing chamber for delivery of medicament |
| US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| CN1949977B (zh) * | 2004-05-04 | 2010-09-29 | 翁启惠 | 抗冠状病毒化合物 |
| WO2005113580A1 (en) * | 2004-05-21 | 2005-12-01 | Pfizer Inc. | Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| WO2006061714A2 (en) * | 2004-12-09 | 2006-06-15 | Pfizer Inc. | Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| CN103562205A (zh) * | 2010-12-16 | 2014-02-05 | 沃泰克斯药物股份有限公司 | 流感病毒复制的抑制剂 |
| CA2850003C (en) | 2011-09-27 | 2020-01-07 | Kansas State University Research Foundation | Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| CN103145608B (zh) | 2011-12-07 | 2015-09-02 | 南开大学 | 抗肠病毒71(ev71)己内酰胺类化合物及其制备方法和用途 |
| CN106928206B (zh) | 2015-12-31 | 2022-02-18 | 中国科学院上海药物研究所 | 醛基类化合物及其制法和用途 |
| WO2017222935A1 (en) | 2016-06-20 | 2017-12-28 | Kansas State University Research Foundation | Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses |
| CN110818691A (zh) | 2018-08-09 | 2020-02-21 | 中国科学院上海药物研究所 | 酮酰胺类化合物及其制备方法、药物组合物和用途 |
| CN110105348A (zh) | 2019-03-08 | 2019-08-09 | 南开大学 | 新型迈克尔受体类肠病毒71型抑制剂的制备及用途 |
-
2021
- 2021-03-17 AU AU2021254045A patent/AU2021254045A1/en active Pending
- 2021-03-17 WO PCT/US2021/022656 patent/WO2021206876A1/en not_active Ceased
- 2021-03-17 KR KR1020227039096A patent/KR20230008079A/ko active Pending
- 2021-03-17 PH PH1/2022/552486A patent/PH12022552486A1/en unknown
- 2021-03-17 JP JP2022561396A patent/JP7721561B2/ja active Active
- 2021-03-17 CA CA3179697A patent/CA3179697A1/en active Pending
- 2021-03-17 EP EP21717692.4A patent/EP4132944A1/en active Pending
- 2021-03-17 IL IL297069A patent/IL297069A/en unknown
- 2021-03-17 BR BR112022019557A patent/BR112022019557A2/pt unknown
- 2021-03-17 MX MX2022012714A patent/MX2022012714A/es unknown
- 2021-03-17 US US17/912,749 patent/US20230159453A1/en active Pending
- 2021-03-17 CN CN202180027505.5A patent/CN115698035A/zh active Pending
- 2021-03-17 TW TW110109546A patent/TW202204318A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023521116A5 (https=) | ||
| RU2401260C2 (ru) | Пиримидиновые производные | |
| RU2003110577A (ru) | Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами | |
| RU2419626C2 (ru) | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы | |
| SI2961736T1 (en) | Histone demethylase inhibitors | |
| JP2022504949A5 (https=) | ||
| AR053652A1 (es) | Derivados de indol como inhibidores de proteina quinasas. composiciones farmaceuticas | |
| AR050619A1 (es) | Derivados de adamantilo | |
| AR044614A1 (es) | Composiciones de sulfonamida que modulan la actividad del receptor de quinioquinas (ccr4) | |
| AR060658A1 (es) | Derivados de diceto-piperazina y piperidina como agentes antivirales | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| PE20090630A1 (es) | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion | |
| AR038214A1 (es) | Compuestos de prolina como inhibidores de la serina proteasa ns3 del virus de la hepatitis c | |
| AR041672A1 (es) | Compuesto biciclico de benzamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y procedimiento para prepararlo | |
| AR082681A1 (es) | Inhibidores del virus de la hepatitis c | |
| RU2012108173A (ru) | Терапевтические арил-амидо-арильные соединения и их применение | |
| JP2011219498A5 (https=) | ||
| JP2008510691A5 (https=) | ||
| JP2009535356A5 (https=) | ||
| RU2008128452A (ru) | Соединения n-(6-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения | |
| AR033379A1 (es) | Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| JP2005511746A5 (https=) | ||
| AR036046A1 (es) | Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos | |
| AR045602A1 (es) | Derivados de benzoilpiperazinas, procesos de obtencion y composiciones farmaceuticas. | |
| AR051156A1 (es) | Compuestos a base de bicicloheteroarilaminas como ligandos de los canales ionicos,usos de los mismos y composiciones farmaceuticas que los contienen |